Skip to content

Back

FDADrugsRecalled

Direct Rx recalls Lidocaine Ointment USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Read the official notice on accessdata.fda.gov
What's wrong
Subpotent Drug
Products
  • Lidocaine Ointment USP
Company
Direct Rx
Where it was sold

Nationwide within the United States

Units affected
493 jars
Status
Ongoing

Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.